Funder
National Health and Medical Research Council
Cancer Australia
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference33 articles.
1. Australian Medical Association. Green light for Medicinal Cannabis but AMA says proceed with caution. Australian Medicine.
https://ama.com.au/ausmed/green-light-medicinal-cannabis-ama-says-proceed-caution
. Accessed 3 Aug 2017.
2. U.S. Food and Drug Administration. Public Health Focus - FDA and Marijuana.
https://www.fda.gov/newsevents/publichealthfocus/ucm421163.htm
. Accessed on 3 Aug 2017.
3. Whiting PF, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456–73.
4. Amar MB. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 2006;105(1):1–25.
5. Shiroiwa T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422–37.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献